• Unlock the Swiss potential – Switzerland’s strength and challenges in the clinical trial framework
• Transforming clinical trials in Switzerland – what can be learnt from others
• Navigate the future – how Switzerland embarks for a new era fit for the future
Archives: Agenda
Morning refreshments and networking
Balancing in-house expertise and outsourcing for trial success
- Comparing in-house and outsourced models for clinical trial execution
- Evaluating decision-making frameworks for choosing the right resourcing strategy
- Identifying key benefits and trade-offs in quality, speed, and flexibility
- Exploring hybrid models and integrating CROs or FSPs effectively
- Adapting operational approaches based on trial complexity, indication, and geography
PANEL DISCUSSION Comparing the all-in-one CRO model to specialized CRO models in clinical development
- Analyzing the efficiency and cost benefits of an all-in-one CRO versus using specialized CROs for different phases
- Evaluating the flexibility of a multi-CRO model in adapting to diverse project needs and expertise
- Weighing the risks of relying on a single provider versus the coordination challenges of managing multiple vendors
- Considering the impact on communication, data integration, and consistency when using a single CRO compared to multiple CROs
- Discussing the potential for innovation and quality improvements with specialized CROs versus the streamlined approach of an all-in-one model
Moderator
| Marie Rasoanandrasana, Head, Supply Chain and Vendor Management, Debiopharm |
PANEL DISCUSSION Exploring shifting clinical trial landscapes and risk strategies
- Exploring how geopolitics influences clinical trials, from trade policies to international relations
- Discussing the impact of political changes and potential policy shifts
- Analyzing regulatory landscapes and incentives in alternative regions
- Addressing risk factors and strategic decision-making for trial site selection
- Examining the role of ERCs and strategy departments in navigating global shifts
| Moderator
Mara Hummel, Associate Director of Global Clinical Operations, Team Leader, Roche |
Registration and refreshments
Chairperson’s opening remarks
DRINKS RECEPTION
Creating the first protocol design with AI: Shortening protocol design processes to less than 3 months
• How AI optimizes clinical trial protocols to reduce errors, streamline processes, and enhance data quality
• A Real-world case study of reduced timelines and improved trial outcomes using Biorce’s platform
• Insights into leveraging predictive analytics for trial success
Operational agility in biotech trials: overcoming bottlenecks across diverse European landscapes
- Identification of critical bottlenecks in multi-country biotech trials and practical methods to resolve them
- Optimisation of project management strategies to accelerate start-up and study conduct without compromising compliance and quality
- Enhancement of collaboration and leveraging of local expertise to ensure quality and timely delivery in European studies